He also mentioned polymerase inhibitors in short "the street" interview at the JP Morgan conference. If you didn't catch it here is the link <A HREF="http://www.thestreet.com/_yahoo/video/executiveinterviews/10331778.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA" target="_blank">http://www.thestreet.com/_yahoo/video/executiveinterviews/10331778.html?cm_ven=YAHOO&cm_cat=...</A> It was interesting how he referred to "other" protease inhibitors (besides SGP). I think the comments of exploring BID dosing speaks more then his comments of other PI's.